Toggle Main Menu Toggle Search

Open Access padlockePrints

Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction

Lookup NU author(s): Dr Salman Razvi

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

The pituitary hormone, thyrotropin (TSH), is regarded as the primary biomarker for evaluating thyroid function, and is useful in guiding treatment with levothyroxine for patients with hypothyroidism. The amplified response of TSH to slight changes in thyroid hormone levels provides a large and easily measured signal in the routine care setting. Laboratories provide reference ranges with upper and lower cut-offs for TSH to define normal thyroid function. The upper limit of the range, used to diagnose subclinical (mild) hypothyroidism is itself a matter for debate, with authoritative guidelines recommending treatment to within the lower half of the range. Concomitant diseases, medications, supplements, age, gender, ethnicity, iodine status, time of day, time of year, autoantibodies, heterophilic antibodies, smoking and other factors influence the level of TSH, or the performance of current TSH assays. The long-term prognostic implications of small deviations of TSH from the reference range are unclear. Correction of TSH to within the reference range does not always bring thyroid and other biomarkers into range, and will not always resolve the patient’s symptoms. Overt hypothyroidism requires intervention with levothyroxine. It remains important that physicians managing a patient with symptoms suggestive of thyroid disease consider all of the patient’s relevant disease, lifestyle and other factors before intervening on the basis of a marginally raised TSH level alone. Finally, these limitations of TSH testing mitigate against screening the population for the undoubtedly substantial prevalence of undiagnosed thyroid disease, until appropriately designed randomised trials have quantified the benefits and harms from this approach.


Publication metadata

Author(s): Razvi S, Bhana S, Mrabeti S

Publication type: Review

Publication status: Published

Journal: Journal of Thyroid Research

Year: 2019

Online publication date: 22/09/2019

Acceptance date: 01/09/2019

ISSN (print): 2090-8067

ISSN (electronic): 2042-0072

URL: https://doi.org/10.1155/2019/4106816

DOI: 10.1155/2019/4106816


Actions

Find at Newcastle University icon    Link to this publication


Share